Hui Wang

Dr. Hui Wang

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
XYXing Yang
Xing Yang
HWHui Wang
Hui Wang
BJBaowei Jiao
Baowei Jiao
Mammary gland stem cells and their application in breast cancer

3 December 2024 in Oncogene
Verified
Journal Article
Closed access
PDF file
HWHairui Wang
Hairui Wang
HWHui Wang
Hui Wang
RWRui Wang
Rui Wang
YLYuanzhen Li
Yuanzhen Li
ZWZhipeng Wang
Zhipeng Wang
BJBaowei Jiao
Baowei Jiao

2 January 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
XYXing Yang
Xing Yang
HXHaibo Xu
Haibo Xu
XYXu Yang
Xu Yang
HWHui Wang
Hui Wang
LZLi Zou
Li Zou
BJBaowei Jiao
Baowei Jiao
While canonical Wnt signaling is well recognized for its crucial regulatory functions in cell fate decisions, the role of non-canonical Wnt signaling in adult stem cells remains elusive and contradictory. Here, we identified Mcam, a potential member of the non-canonical Wnt signaling, as an important negative regulator of mammary gland epithelial cells (MECs) by genome-scale CRISPR-Cas9 knockout (GeCKO) library screening. Loss of Mcam increases the clonogenicity and regenerative capacity of MECs, and promotes the proliferation, differentiation, and ductal morphogenesis of mammary epithelial in knockout mice. Mechanically, Mcam knockout recruits and polarizes macrophages through the Il4-Stat6 axis, thereby promoting secretion of the non-canonical Wnt ligand Wnt5a and its binding to the non-canonical Wnt signaling receptor Ryk to induce the above phenotypes. These findings reveal Mcam roles in mammary gland development by orchestrating communications between MECs and macrophages via a Wnt5a/Ryk axis, providing evidences for non-canonical Wnt signaling in mammary development.

10 May 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
HSHaili Shao
Haili Shao
JHJipeng Huang
Jipeng Huang
HWHui Wang
Hui Wang
GWGuolei Wang
Guolei Wang
XYXu Yang
Xu Yang
BJBaowei Jiao
Baowei Jiao
Efficient milk production in mammals confers evolutionary advantages by facilitating the transmission of energy from mother to offspring. However, the regulatory mechanism responsible for the gradual establishment of milk production efficiency in mammals, from marsupials to eutherians, remains elusive. Here, we find that mammary gland of the marsupial sugar glider contained milk components during adolescence, and that mammary gland development is less dynamically cyclic compared to that in placental mammals. Furthermore, fused in sarcoma (FUS) is found to be partially responsible for this establishment of low efficiency. In mouse model, FUS inhibit mammary epithelial cell differentiation through the cyclin-dependent kinase inhibitor p57Kip2, leading to lactation failure and pup starvation. Clinically, FUS levels are negatively correlated with milk production in lactating women. Overall, our results shed light on FUS as a negative regulator of milk production, providing a potential mechanism for the establishment of milk production from marsupial to eutherian mammals.

15 October 2025 in BMC Genomics
Verified
Journal Article
Open access
PDF file
FWFeifan Wang
Feifan Wang
LWLin Wang
Lin Wang
LZLi Zou
Li Zou
XZXiusen Zhang
Xiusen Zhang
QYQin Yang
Qin Yang
HWHui Wang
Hui Wang
Lactation physiological activity plays a key role in maternal health as well as infant nutrition and growth. The complex gene regulatory networks of lactation remain largely unexplored during mammary gland development. A deeper understanding of these processes is essential for identifying potential therapeutic targets to improve lactation efficiency. We employed Gene Co-expression Network Analysis (WGCNA) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis to identify the gene expression patterns, regulatory mechanisms and cellular signaling pathways involved in mammary gland development during pregnancy and lactation. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to validate gene expression in mRNA levels at different stages of mammary development. Immunohistochemical staining was carried out to detect the protein level of ACSS1 at different stages of mammary development. Lactogenic differentiation assay and triglyceride (TAG) secretion detection were applied to investigate the effect of Acss1 on lactogenic differentiation and milk lipid metabolism during lactation. We identified 23 gene modules, among which 8 modules were activated during pregnancy and lactation stage of mammary gland development. Cellular signaling pathways associated with mammary gland differentiation were enriched, including the FOXO and Wnt signaling pathways during pregnancy, as well as steroid biosynthesis and fatty acid metabolism during lactation. Among the identified genes, Acss1 emerged as a potential hub gene within module 8, exhibiting high connectivity with 312 other genes, and playing a critical role in lactogenic differentiation and milk lipid metabolism. Experimental validation showed that the gene expression pattern of Acss1 were highly consistent with microarray data at different stages of mammary gland development. Lactogenic differentiation assay and TAG secretion detection showed that Acss1 is crucial for lactogenic differentiation and affects the production and secretion of TAG during lactation in vitro. These findings suggesting Acss1 as a potential key regulatory factor of lactation efficiency.

30 January 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
XZXiusen Zhang
Xiusen Zhang
XZXudong Zhang
Xudong Zhang
XJXing Jin
Xing Jin
SZShilei Zhang
Shilei Zhang
XZXin Zhao
Xin Zhao
SGShegan Gao
Shegan Gao
Esophageal squamous cell carcinoma (ESCC) represents a major therapeutic challenge due to the rapid development of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs). Recent evidence highlights that this resistance is driven not only by genetic mutations but also by spatial heterogeneity of tumor microenvironments and compensatory signaling mechanisms. In this review, we propose a “spatial-signaling-intervention” framework with a particular focus on the NTRK2/MAPK signaling axis, which plays dual roles in signaling compensation and immune evasion. By integrating spatial multi-omics, proteomics, and AI-assisted topological modeling, three resistant niches are identified: (1) cancer stemness-enriched zones, (2) MAPK hyperactive islands, and (3) immune-cold regions. Based on this atlas, we design precision nanotherapeutic platforms, including responsive, dual-target, and feedback-loop nanocarriers, to selectively modulate resistant spatial niches. Preclinical validation in patient-derived xenografts and organoid models further demonstrates the translational potential of these strategies. This work provides a conceptual and technological roadmap for overcoming EGFR-TKI resistance in ESCC. Atlas-guided nanocarrier systems offer a promising avenue for spatially targeted and feedback-responsive therapy, highlighting the role of pharmaceutics in advancing precision oncology.